Zegfrovy Sunvozertinib 150 mg Tablet

Zegfrovy Sunvozertinib 150 mg Tablet

90000.00 INR In stock Buy at Merchant

Zegfrovy 150 mg is a selective EGFR tyrosine kinase inhibitor for treating locally advanced or metastatic non-small cell lung cancer with EGFR Exon 20 insertion mutations.

  • The description claims it is indicated for patients who have progressed on or after platinum-based chemotherapy.

AI Readiness

Good foundation, but some important product data is still missing.

66%
4 important fields missing Claim to view full AI report
Data sourced from www.milanmedicals.com. Last updated: The description was auto-generated by an AI model based on the merchant's description. It may not be accurate or complete.
Claim www.milanmedicals.com to see AI Product Health

Takes ~2 minutes. No storefront changes.